Position in MSLE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,970,500
New position
Shares Held
350,000
first reported quarter
Ownership
1.68%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Saturn V Capital Management LP holds $491,754,102 across 20 Biotechnology names. MSLE ranks #20 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALMS |
Alumis Inc.
|
3,202,075 | $70,541,712 | |
| 2 | ABVX |
Abivax S.A.
|
542,696 | $60,429,199 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
824,532 | $47,913,554 | |
| 4 | PHVS |
Pharvaris N.V.
|
1,201,402 | $33,939,606 | |
| 5 | IMMX |
Immix Biopharma, Inc.
|
3,693,585 | $33,648,559 | |
| 6 | CELC |
Celcuity Inc.
|
281,904 | $32,176,522 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
162,961 | $30,807,777 | |
| 8 | IRON |
Disc Medicine, Inc.
|
449,926 | $28,768,268 |
All Filings in MSLE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,970,500 | 350,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||